Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel
Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel reported $16.6 million in revenue and $16.6 million in expenses for calendar year 2024. Of every $100 it spent, $92.86 went to program services, $7.14 to management and general costs and $0.00 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 97.5% of the total. The highest compensation it reported for one person was $6,979,162 (BOARD MEMBER). 27 people received more than $100,000 in reportable compensation. Revenue fell 8% between 2019 and 2024. Source: Form 990, 2024.
Where $100 of spending went
Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $17MFor context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2024 · Form 990, Part VIII · total revenue $17MThe 990 scorecard · same measures for every charity, no grades
| Measure | 2024 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 92.9% | 83.9% |
| Management & general Part IX 25(C) ÷ 25(A) | 7.1% | 12.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.0% | 0.1% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.00 | $0.01 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 2.0% | 72.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.0% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 97.5% | 5.8% |
| Highest reported compensation Part VII-A, columns D–F | $6,979,162 | $628,890 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 42.10% | 1.94% |
| People paid over $100,000 Part VII, line 2 | 27 | 18 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 0.0 | 13.3 |
| Independent voting board members Part VI 1a–1b | 0 of 9 | 93.8% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2024 · Form 990, Part III · the three largest programs by expenseThe Sanders Tri-Institutional Therapeutics discovery institute, a partnership among three world-renowned scientific and medical institutions, works to more effectively develop therapeutics that arise from discoveries made in basic science labs. With a focus on early-stage drug discovery, the institute provides expertise in medicinal chemistry and compound screening, and conducts proof of concept studies needed to demonstrate that drug candidates can successfully alter the course of a disease. Specific research projects focus on alzheimers disease, sickle cell, osteoporosis, lysosomal, lipid…
The institute facilitates more efficient sharing of core facilities between the three partner institutions and forms industry partnerships with pharmaceutical and biotech companies to further advance drug research. It seeks to create intellectual property that can be further developed by an open field of industry collaborators. The majority of such services relate to medicinal chemistry support
Highest reported compensation
2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| BOARD MEMBER Director/trustee, 0.50 hrs/week | $0 | $6,637,012 | $342,150 | $6,979,162 |
| BOARD MEMBER Director/trustee, 0.50 hrs/week | $0 | $2,666,653 | $43,901 | $2,710,554 |
| BOARD MEMBER Director/trustee, 0.50 hrs/week | $0 | $1,308,593 | $285,349 | $1,593,942 |
| BOARD MEMBER Director/trustee, 0.50 hrs/week | $0 | $810,638 | $50,274 | $860,912 |
| BOARD MEMBER Director/trustee, 0.50 hrs/week | $0 | $716,817 | $123,955 | $840,772 |
| BOARD MEMBER Director/trustee, 0.50 hrs/week | $0 | $685,687 | $71,956 | $757,643 |
| SANDERS DIRECTOR Officer, 40.00 hrs/week | $627,542 | $0 | $68,608 | $696,150 |
| BOARD MEMBER Director/trustee, 0.50 hrs/week | $0 | $625,253 | $68,608 | $693,861 |
27 people received more than $100,000 in reportable compensation from Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel (Part VII, line 2). Compensation of current officers, directors and key employees totaled $615K (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b9 · 0 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 532
Largest outside contractors
2024 · Form 990, Part VII, Section B · businesses only| WUXI Prof svcs-research | $2,620,525 |
| ABLEXIS LLC Prof svcs-research | $1,000,000 |
| SINGLE CELL TECHNOLOGY Prof svcs-research | $301,099 |
| WUXI BIOLOGICS Prof svcs-research | $199,207 |
| VIVA BIOTECH (SHANGHAI) LTD Prof svcs-research | $172,386 |
Individuals listed as contractors are left out. 6 contractors were paid more than $100,000 in all.
Correct a figure or respond
Every number above is copied from Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel spent in 2024, $92.86 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- William K Warren Medical Research CenterTulsa, OK · revenue $16M · programs 64.8% · 2024
- The American Society of Gene & Cell TherapyWaukesha, WI · revenue $17M · programs 80.1% · 2024
- ALS Therapy Development FoundationWatertown, MA · revenue $16M · programs 90.5% · 2025
- The American Academy of Allergy AsthmaMilwaukee, WI · revenue $18M · programs 63.2% · 2024
- Veterans Medical Research Foundation of San DiegoSan Diego, CA · revenue $16M · programs 71.4% · FY2025
All medical research charities · Largest charities in New York
Questions people ask
How much of Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel's spending goes to programs?
In calendar year 2024, Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel reported that 92.9% of its $16.6 million in expenses went to program services, 7.1% to management and general and 0.0% to fundraising (Form 990, Part IX).
How much does Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel pay its top executive?
The largest total compensation Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel reported for one person in calendar year 2024 was $6,979,162, for the role of BOARD MEMBER (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel get its money?
Of $16.6 million in revenue in calendar year 2024, 2.0% came from contributions and grants and 97.5% from program service revenue (Form 990, Part VIII).
Is Sanders Tri-Institutional Therapeutics Discovery Institute Inc. Co Weill Cornel a registered charity?
The IRS lists EIN 46-3673346 as a 501(c)(3) organization (supporting organization, type i), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2024: Form 990 for calendar year 2024, object 202503019349300820 · read the filing · XML
- 2023: Form 990 for calendar year 2023, object 202422959349300142 · read the filing
- 2022: Form 990 for calendar year 2022, object 202313119349302456 · read the filing
- 2021: Form 990 for calendar year 2021, object 202232909349301948 · read the filing
- 2020: Form 990 for calendar year 2020, object 202143129349302104 · read the filing
- 2019: Form 990 for calendar year 2019, object 202003109349300240 · read the filing
All filings for EIN 46-3673346: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.